Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT01113632 · COMPLETED
Trial details
- NCT number
- NCT01113632
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2015-03-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.